Painreform Ltd (PRFX)

$1.13 +0.31 (37.96%)
Market Cap 2.28M
Revenue (ttm) 0.00
Net Income (ttm) -14.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 64,154,902
Avg Vol 2,111,514
Day's Range N/A - N/A
Shares Out 2.01M
Stochastic %K 50%
Beta 0.59
Analysts Strong Buy
Price Target $47.99

Company Profile

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Te...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 3 7177050
Address:
65 Yigal Alon St., Tel Aviv-Yafo, Israel
SA449
SA449 Sep. 20 at 4:05 PM
$PRFX
0 · Reply
SA449
SA449 Sep. 18 at 6:12 PM
$PRFX 🟢🟢🟢
0 · Reply
SA449
SA449 Sep. 18 at 1:01 PM
$PRFX LET'S GO! 🚀📈🔥💲🪙🤑💰🟢 $AMD " EXTREMELY BULLISH! " $NVDA $TSLA $META
0 · Reply
SA449
SA449 Sep. 17 at 7:45 PM
$PRFX 🟢🟢🟢
0 · Reply
SA449
SA449 Sep. 17 at 6:06 PM
$PRFX TO THE TOP 🚀📈🔥💲🤑🪙💰🟢
0 · Reply
SA449
SA449 Sep. 17 at 4:54 PM
$PRFX Always Be Optimistic 🟢🟢🟢
0 · Reply
SA449
SA449 Sep. 17 at 2:15 PM
$PRFX TO THE TOP! 🚀📈🔥💲🤑🟢🪙💰
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 17 at 2:14 PM
$PRFX here it goes again
0 · Reply
SA449
SA449 Sep. 17 at 12:56 PM
$PRFX We hope 🙏 $PRFX performs better than $AEMD
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 17 at 12:26 PM
$PRFX glad to see you finally noticing
0 · Reply
Latest News on PRFX
PRF Technologies' GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization

Sep 16, 2026, 9:00 AM EDT - 4 days ago

PRF Technologies' GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization

PRF Technologies to Establish GridFeed™ as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform

Sep 9, 2026, 8:30 AM EDT - 11 days ago

PRF Technologies to Establish GridFeed™ as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform

PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business

Sep 3, 2026, 8:30 AM EDT - 17 days ago

PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business

PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms

Jul 27, 2026, 8:30 AM EDT - 7 weeks ago

PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms

PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026

Jul 21, 2026, 8:30 AM EDT - 2 months ago

PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026

PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets

Jul 15, 2026, 9:15 AM EDT - 2 months ago

PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets

PRF Technologies' DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data

Jul 8, 2026, 8:30 AM EDT - 2 months ago

PRF Technologies' DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data

PRF Technologies announces expanded results from PRF-110 study

2026-06-25T13:00:40.000Z - 2 months ago

PRF Technologies announces expanded results from PRF-110 study

PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark

Jun 25, 2026, 8:30 AM EDT - 2 months ago

PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark

PRF Technologies files to sell 7.5M ordinary shares for holders

2026-06-22T20:24:38.000Z - 3 months ago

PRF Technologies files to sell 7.5M ordinary shares for holders

Why Is Penny Stock PRF Technologies (PRFX) Up Today?

2026-05-30T01:19:00.000Z - 3 months ago

Why Is Penny Stock PRF Technologies (PRFX) Up Today?

PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets

May 28, 2026, 8:30 AM EDT - 3 months ago

PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets

PRF Technologies announces results from study comparing PRF-110 to Zynrelef

2026-05-26T14:53:02.000Z - 3 months ago

PRF Technologies announces results from study comparing PRF-110 to Zynrelef

PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

May 26, 2026, 8:30 AM EDT - 3 months ago

PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

PRF Technologies registers to sell 3M ordinary shares for holders

2026-05-13T20:53:11.000Z - 4 months ago

PRF Technologies registers to sell 3M ordinary shares for holders

PRF Technologies announces FDA clearance of OcuRing-K NDA

2026-04-28T13:13:35.000Z - 4 months ago

PRF Technologies announces FDA clearance of OcuRing-K NDA

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

Apr 28, 2026, 8:00 AM EDT - 4 months ago

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

Mar 27, 2026, 8:00 AM EDT - 5 months ago

PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

PRF Technologies signs commercial collaboration agreement with Blade Ranger

2026-03-17T12:55:36.000Z - 6 months ago

PRF Technologies signs commercial collaboration agreement with Blade Ranger

PRF Technologies Ltd. Announces Commercial Collaboration Agreement with Blade Ranger to Accelerate Large-Scale DeepSolar Commercial Engagements

Mar 17, 2026, 8:30 AM EDT - 6 months ago

PRF Technologies Ltd. Announces Commercial Collaboration Agreement with Blade Ranger to Accelerate Large-Scale DeepSolar Commercial Engagements

PRF Technologies’ DeepSolar announces commercial due diligence engagement

2026-02-18T14:25:31.000Z - 7 months ago

PRF Technologies’ DeepSolar announces commercial due diligence engagement

PRF Technologies' DeepSolar Announces its First Commercial Due Diligence Engagement with EDF Power Solutions Israel, a Global Leader in Renewable Energy

Feb 18, 2026, 9:15 AM EST - 7 months ago

PRF Technologies' DeepSolar Announces its First Commercial Due Diligence Engagement with EDF Power Solutions Israel, a Global Leader in Renewable Energy

PRF Technologies signs SaaS agreement with Shikun & Binui Energy

2026-02-11T13:41:18.000Z - 7 months ago

PRF Technologies signs SaaS agreement with Shikun & Binui Energy

PRF Technologies Wins Another European Utility-Scale Solar Deployment, Expanding DeepSolar's Installed Commercial Base

Feb 11, 2026, 8:30 AM EST - 7 months ago

PRF Technologies Wins Another European Utility-Scale Solar Deployment, Expanding DeepSolar's Installed Commercial Base

PRF Technologies Ltd trading halted, news pending

2026-02-06T00:50:31.000Z - 7 months ago

PRF Technologies Ltd trading halted, news pending

PRF files first patent application for solar plant-level micro-climate modeling

2026-01-20T14:20:31.000Z - 8 months ago

PRF files first patent application for solar plant-level micro-climate modeling

PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy

Jan 20, 2026, 9:05 AM EST - 8 months ago

PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy

PainReform changes name to PRF Technologies

2026-01-15T21:10:29.000Z - 8 months ago

PainReform changes name to PRF Technologies

PainReform Ltd. Changes Name to PRF Technologies Ltd.

Jan 15, 2026, 4:05 PM EST - 8 months ago

PainReform Ltd. Changes Name to PRF Technologies Ltd.

PainReform announces safety data supporting development of OcuRing-K platform

2026-01-12T14:22:52.000Z - 8 months ago

PainReform announces safety data supporting development of OcuRing-K platform

PainReform's LayerBio's Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies

Jan 12, 2026, 9:00 AM EST - 8 months ago

PainReform's LayerBio's Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies

PainReform’s DeepSolar launches Smart TDD service

2026-01-05T14:15:52.000Z - 8 months ago

PainReform’s DeepSolar launches Smart TDD service

PainReform's DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market

Jan 5, 2026, 9:00 AM EST - 8 months ago

PainReform's DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market

BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week

Dec 30, 2025, 8:48 AM EST - 8 months ago

BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week

PainReform completed R&D assessment of LayerBio’s drug-delivery platform

2025-12-10T13:50:56.000Z - 9 months ago

PainReform completed R&D assessment of LayerBio’s drug-delivery platform

PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities

Dec 10, 2025, 8:30 AM EST - 9 months ago

PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities

PainReform commences development plan for OcuRing-K Phase II trial

2025-12-02T14:25:25.000Z - 9 months ago

PainReform commences development plan for OcuRing-K Phase II trial

PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy

Dec 2, 2025, 9:15 AM EST - 9 months ago

PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy

PainReform’s DeepSolar advances development of AI-driven reporting engine

2025-11-12T14:10:39.000Z - 10 months ago

PainReform’s DeepSolar advances development of AI-driven reporting engine

PainReform's DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis

Nov 12, 2025, 9:00 AM EST - 10 months ago

PainReform's DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis

PainReform's DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link's “Watchlist Interview” and Announces Progress Toward Pilot Projects

Nov 5, 2025, 8:30 AM EST - 10 months ago

PainReform's DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link's “Watchlist Interview” and Announces Progress Toward Pilot Projects

PainReform reports 1H EPS ($1.09) vs. ($63.15) last year

2025-10-01T13:35:32.000Z - 11 months ago

PainReform reports 1H EPS ($1.09) vs. ($63.15) last year

PainReform Provides Business Update for the Six Months Ended June 30, 2025

Oct 1, 2025, 9:27 AM EDT - 11 months ago

PainReform Provides Business Update for the Six Months Ended June 30, 2025

PainReform’s DeepSolar accepted into Nvidia Connect Program

2025-08-19T12:50:33.000Z - 1 year ago

PainReform’s DeepSolar accepted into Nvidia Connect Program

NVDA

PainReform/DeepSolar Accepted into NVIDIA Connect Program

Aug 19, 2025, 8:30 AM EDT - 1 year ago

PainReform/DeepSolar Accepted into NVIDIA Connect Program

PainReform completes strategic investment in LayerBio

2025-08-13T12:40:28.000Z - 1 year ago

PainReform completes strategic investment in LayerBio

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

Aug 13, 2025, 8:30 AM EDT - 1 year ago

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System

PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio

Jul 10, 2025, 8:30 AM EDT - 1 year ago

PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with LayerBio

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

May 27, 2025, 12:12 PM EDT - 1 year ago

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar Projects

May 7, 2025, 4:30 PM EDT - 1 year ago

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania's Largest Solar Projects

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market

Apr 10, 2025, 8:30 AM EDT - 1 year ago

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market

PainReform Provides Year-End Business Update

Apr 7, 2025, 5:00 PM EDT - 1 year ago

PainReform Provides Year-End Business Update

PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics

Mar 5, 2025, 11:00 AM EST - 1 year ago

PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics

PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity

Feb 18, 2025, 8:30 AM EST - 1 year ago

PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity

PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110

Dec 27, 2024, 8:30 AM EST - 1 year ago

PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

Nov 20, 2024, 8:30 AM EST - 1 year ago

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

Nov 7, 2024, 5:00 PM EST - 1 year ago

PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

Sep 11, 2024, 8:30 AM EDT - 2 years ago

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

Sep 10, 2024, 9:46 AM EDT - 2 years ago

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study

Aug 20, 2024, 8:30 AM EDT - 2 years ago

PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study

PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses

Aug 7, 2024, 10:00 AM EDT - 2 years ago

PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses

PainReform's New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature

Aug 1, 2024, 8:30 AM EDT - 2 years ago

PainReform's New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature

PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification

May 31, 2024, 4:15 PM EDT - 2 years ago

PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification

PainReform Provides Business Update for the First Quarter of 2024

May 15, 2024, 4:05 PM EDT - 2 years ago

PainReform Provides Business Update for the First Quarter of 2024

PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com

May 8, 2024, 8:30 AM EDT - 2 years ago

PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com

PainReform Announces Closing of $4 Million Public Offering

Apr 18, 2024, 2:19 PM EDT - 2 years ago

PainReform Announces Closing of $4 Million Public Offering

PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions

Apr 9, 2024, 9:00 AM EDT - 2 years ago

PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions

PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy

Apr 2, 2024, 8:30 AM EDT - 2 years ago

PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy

PainReform to Present at the Microcap Conference in Atlantic City

Jan 22, 2024, 8:30 AM EST - 2 years ago

PainReform to Present at the Microcap Conference in Atlantic City

PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief

Jan 3, 2024, 8:30 AM EST - 2 years ago

PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief

SA449
SA449 Sep. 20 at 4:05 PM
$PRFX
0 · Reply
SA449
SA449 Sep. 18 at 6:12 PM
$PRFX 🟢🟢🟢
0 · Reply
SA449
SA449 Sep. 18 at 1:01 PM
$PRFX LET'S GO! 🚀📈🔥💲🪙🤑💰🟢 $AMD " EXTREMELY BULLISH! " $NVDA $TSLA $META
0 · Reply
SA449
SA449 Sep. 17 at 7:45 PM
$PRFX 🟢🟢🟢
0 · Reply
SA449
SA449 Sep. 17 at 6:06 PM
$PRFX TO THE TOP 🚀📈🔥💲🤑🪙💰🟢
0 · Reply
SA449
SA449 Sep. 17 at 4:54 PM
$PRFX Always Be Optimistic 🟢🟢🟢
0 · Reply
SA449
SA449 Sep. 17 at 2:15 PM
$PRFX TO THE TOP! 🚀📈🔥💲🤑🟢🪙💰
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 17 at 2:14 PM
$PRFX here it goes again
0 · Reply
SA449
SA449 Sep. 17 at 12:56 PM
$PRFX We hope 🙏 $PRFX performs better than $AEMD
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 17 at 12:26 PM
$PRFX glad to see you finally noticing
0 · Reply
RiseAboveAll752
RiseAboveAll752 Sep. 17 at 12:25 PM
$PRFX news yesterday was good. One day like $AEMD one of the smallest floats I've seen just no one knows its here
0 · Reply
SA449
SA449 Sep. 17 at 10:27 AM
$PRFX We hope today a great thing will happen! 🙏🚀📈🪙🔥💲🤑🟢
0 · Reply
topstockalerts
topstockalerts Sep. 16 at 8:05 PM
$PRFX not exactly explosive, but very difficult to ignore.
0 · Reply
SA449
SA449 Sep. 16 at 6:01 PM
$MEDS I Think The Next big thing will be $PRFX 🚀📈🔥💲🤑🟢
0 · Reply
SA449
SA449 Sep. 16 at 5:58 PM
$PRFX
0 · Reply
ShadowSnake
ShadowSnake Sep. 16 at 4:19 PM
$MEDS bring profits over to $PRFX .. just released positive news.. let’s run it
0 · Reply
ShadowSnake
ShadowSnake Sep. 16 at 4:11 PM
$PRFX holding this POS and it barely moves on news meanwhile not in $MEDS and it goes bonkers… just my luck
0 · Reply
SA449
SA449 Sep. 16 at 3:56 PM
$PRFX $MEDS I hope it reaches $16 🙏🚀📈🔥🤑🟢🟢🟢
0 · Reply
Wallstdiamonds
Wallstdiamonds Sep. 16 at 3:53 PM
$PRFX has a setup that resembles $MEDS before its major move a tiny float former healthcare/biotech company undergoing an AI-focused transition, creating a completely new narrative and potentially attracting a new group of speculative traders. The combination of a very small share structure, AI pivot, new partnerships/catalysts, and increased attention can create significant volatility if volume comes in.
0 · Reply
BigPlaySnipers
BigPlaySnipers Sep. 16 at 3:42 PM
Halts on halts, shorts getting killed this week on small caps $PRFX data center news, tiny float , with cash. Maybe this catches next
1 · Reply
Wallstdiamonds
Wallstdiamonds Sep. 16 at 3:40 PM
Small caps heating up $SDST $PRFX huge moves brewing
0 · Reply
Gerol
Gerol Sep. 16 at 3:01 PM
$PRFX the next $MEDS ???
1 · Reply